Jim Simons Aquestive Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 95,400 shares of AQST stock, worth $278,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,400

Previous 28,600 233.57%

Holding current value

$278,568

Previous $142,000 137.32%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$3.46 - $5.64 $231,128 - $376,752	66,800 Added 233.57%	95,400 $337,000
Q3 2024 Nov 13, 2024	SELL	$2.4 - $5.09 $1.12 Million - $2.38 Million	-467,600 Reduced 94.24%	28,600 $142,000
Q2 2024 Aug 09, 2024	SELL	$2.31 - $4.5 $2.03 Million - $3.96 Million	-879,600 Reduced 63.93%	496,200 $1.29 Million
Q1 2024 May 13, 2024	BUY	$2.01 - $6.09 $209,642 - $635,187	104,300 Added 8.2%	1,375,800 $5.86 Million
Q4 2023 Feb 13, 2024	BUY	$1.29 - $2.47 $183,581 - $351,508	142,311 Added 12.6%	1,271,500 $2.57 Million
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.24 $151,510 - $226,255	-101,007 Reduced 8.21%	1,129,189 $1.73 Million
Q2 2023 Aug 11, 2023	BUY	$1.06 - $2.49 $754,079 - $1.77 Million	711,396 Added 137.12%	1,230,196 $2.03 Million
Q1 2023 May 12, 2023	BUY	$0.72 - $1.15 $40,365 - $64,472	56,063 Added 12.12%	518,800 $591,000
Q4 2022 Feb 13, 2023	SELL	$0.77 - $1.18 $337,308 - $516,914	-438,063 Reduced 48.63%	462,737 $417,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $1.73 $205,128 - $563,288	-325,600 Reduced 26.55%	900,800 $1.05 Million
Q2 2022 Aug 12, 2022	BUY	$0.64 - $2.57 $762,944 - $3.06 Million	1,192,100 Added 3475.51%	1,226,400 $785,000
Q1 2022 May 13, 2022	BUY	$2.28 - $4.26 $52,538 - $98,163	23,043 Added 204.7%	34,300 $90,000
Q4 2021 Feb 11, 2022	SELL	$3.69 - $6.37 $658,340 - $1.14 Million	-178,412 Reduced 94.06%	11,257 $44,000
Q3 2021 Nov 12, 2021	SELL	$3.25 - $4.66 $181,281 - $259,930	-55,779 Reduced 22.73%	189,669 $827,000
Q2 2021 Aug 13, 2021	BUY	$3.29 - $5.21 $807,523 - $1.28 Million	245,448 New	245,448 $974,000
Q1 2021 May 13, 2021	SELL	$4.17 - $6.73 $1.13 Million - $1.83 Million	-271,800 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$4.65 - $7.79 $1.26 Million - $2.12 Million	271,800 New	271,800 $1.45 Million
Q2 2020 Aug 13, 2020	SELL	$1.84 - $6.44 $541,053 - $1.89 Million	-294,051 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.54 - $6.75 $331,178 - $1.45 Million	215,051 Added 272.22%	294,051 $644,000
Q4 2019 Feb 13, 2020	BUY	$3.06 - $8.78 $241,740 - $693,620	79,000 New	79,000 $460,000

Others Institutions Holding AQST

# of Institutions

122

Shares Held

47.1M

Call Options Held

517K

Put Options Held

207K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $156M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account